登录 | 注册    微信公众号  
搜索
 > 【TACI】

TIGIT 分子别名

TIGIT,VSIG9,VSTM3

TIGIT 分子背景

TIGIT has been shown to be over expressed on tumor antigen-specific CD8+ T cells and CD8+ tumor infiltrating lymphocytes (TIL). Blockade of TIGIT led to increased cell proliferation, cytokine production, and degranulation of TA-specific CD8+ T cells and TIL CD8+ T cells, which now make it be considered as an immune checkpoint. Recently, studies have shown anti-TIGIT antibody is promising to become a cancer immunotherapy. Our ELISA kit is designed to help the discovery of anti-TIGIT therapeutic antibody.

TIGIT 前沿进展

消息提示

请输入您的联系方式,再点击提交!

确定